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Bovine mastitis causes large annual economic losses around the world. Different
microorganisms are associated with the disease. The capacity of pathogens to adhere
to bovine mammary epithelial cells is associated with biofilm production which leads
to antibiotic resistance. Research is now leading to search alternative control methods
and medicinal plants constitute a natural, safe, effective and inexpensive option.
Minthostachys verticillata is an autochthonous medicinal plant of Argentina with multiple
ethnobotanical properties. In a previous study, we demonstrated that the essential oil
(EO) of this species and limonene, one of its compounds, inhibited the growth of mastitis
pathogens. The objective of the present work was to determine the inhibitory effect of
the essential oil ofM. verticillata and limonene, on biofilm formation and on mature biofilm
produced by pathogens isolated from bovine mastitis. Time kill assay and bacterial lysis
were also determined. Furthermore, RAPD-PCR assays were performed to determine
changes in bacterial DNA after EO and limonene exposition. Bacterial isolates were
identified as Escherichia coli (EC3 and EC9), Bacillus pumilus (BP5, BP6, and BP7) and
Enterococcus faecium (EF1) by rRNA 16S sequencing andMALDI-TOFMS. All the strains
were able to form biofilm. Addition of both lactose and sucrose did not affect biofilm
production. MIC values for EO were 3.6 mg/ml for E. faecium; 0.9 mg/ml for E. coli (EC3),
14.5 mg/ml for E. coli (EC9), 1.8 mg/ml for B. pumilus (BP7), 3.63 mg/ml for B. pumilus
(BP6) and 29.0 mg/ml for B. pumilus (BP7). MIC values for limonene were 6.6 mg/ml for
B. pumilus (BP6) and 105 mg/ml for B. pumilus (BP5). These results demonstrated that
EOwasmore effective than limonene, showing also bactericidal action against E. faecium
(minimal inhibitory concentration (MBC) = 29.0 mg/ml). This result was corroborated by
time of death assay, observing a cell decrease after at 6 h, and then by bacterial lysis
assay. Both EO and limonene affected mature biofilm of isolated strains. The results
contribute to the study of EO and limonene which may serve as a therapy against bovine
mastitis pathogens inhibiting the development of pathogenic bacteria.
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INTRODUCTION
Bovine mastitis is a disease that causes large annual economic
losses around the world. Different pathogens, classified as
environmental and contagious, are associated with the disease as
their ability to form biofilm leads to the advance of the infection
(1). Reports showed that mastitis pathogens are able to form
biofilms (2–4). The establishment of the biofilm depends on the
ability of the pathogen to adhere to bovine mammary epithelial
cells. Biofilm is composed of a matrix that protects the cells from
unfavorable conditions. Mastitis agents growing on biofilm are
more resistant to antimicrobial agents (5).
Whereas antibiotic therapy has a positive impact on the udder
health and milk production, it is not always effective and leaves
residues with implications for human health. In addition, the
ability of pathogens to live in the mammary gland forming
biofilm, would be a potential source of persistent or chronic
infection (6). The ability to invade mammary epithelial cells
and the intracellular survival of bacterial agents also has a
role in the pathogenesis of persistent mastitis. Generally, these
infections are difficult to treat (7). New approaches aim to
generate and to increase immune protection in the sick udder
during immunosuppressive periods, leading to a significant effect
on resistance to infection (8).
Alternative control methods are currently being sought, and
medicinal plants can be a natural, safe, effective and inexpensive
option for the treatment of this disease.Minthostachys verticillata
is an aromatic and autochthonous medicinal plant, native of
Cordoba province, Argentina. It is one of the most used in folk
medicine due to multiple ethnobotanical therapeutic properties
(9). In a previous study, we demonstrated that the essential
oil (EO) of this species and limonene, one of its compounds,
inhibited the growth of Streptococcus uberis causing bovine
mastitis (10). Additionally, we showed that EO and limonene also
have antimicrobial effect on major mastitis pathogens such as
Staphylococcus aureus, Streptococcus uberis, Escherichia coli and
Coagulase-Negative Staphylococci (CNS) by disk diffusion assay
(11).
The objective of the present work was to determine the
inhibitory effect of the essential oil of Minthostachys verticillata
and limonene, on biofilm formation and on mature biofilm
produced by pathogens isolated from bovine mastitis. For
this, minimal inhibitory concentration and minimal bactericide
concentration (MCB) were evaluated. Time kill assay and
bacterial lysis were also determined. Furthermore, Random
Amplified of Polymorphic DNA (RAPD-PCR) assay was




The EO (δ = 0.929 g/ml) was obtained from the aerial parts of
the plant by hydrodistillation according to Montironi et al. (10).
The identification of the main components was carried out by
Gas Chromatography-Mass Spectrometry (GC-MS) comparing
the retention times of these compounds with those of standard
drugs: pulegone, mentone, limonene, cineole, α-pinene, and
β-pinene. GC-MS was performed by the service of Instituto
Multidisciplinario de Biología Vegetal (IMIV-Conicet), Cátedra
de Química Orgánica, Facultad de Ciencias Exactas, Físicas y
Naturales, Universidad Nacional de Córdoba. Limonene was
purchased from Sigma Aldrich (St. Louis, USA) as (R)-(+)-
Limonene (δ= 0.840 g/ml).
To perform the different tests, EO and limonene first dissolved
in DMSO 1:2 (1 part of EO or limonene and 2 parts of DMSO)
and then in PBS 1:10 (1 part of mixture of EO or limonene with
DMSO and 10 parts of PBS) were used. Serial dilutions (1/2) were
performed resulting in concentrations from 929 to 0.45 mg/ml
and 840 to 0.41 mg/ml for EO and limonene, respectively.
Bacterial Isolates
Fifteen milk samples were collected from cows, with subclinical
mastitis, belonging to a dairy herd located in the central dairy
region of Argentina 130 km away from Rio Cuarto city. The dairy
herd was visited once during August 2016. The average herd size
was 130 milking cows.
Samples were immediately refrigerated at 4◦C and subjected to
bacteriological analysis within 24 h of isolation. The isolates were
cultured on blood agar plates with 5% bovine blood. Nine of them
showed to have more than three different colony types, for which
they were considered as contaminated according to Hogan et al.
(12). Six samples, which had only one type of colony, were used in
the present study. Then, isolates were cultured on Trypticase Soy
Agar (TSA) (Britania) for 24 h at 37◦C and were presumptively
identified based on colonial appearance, Gram stain reaction
and catalase test. Isolates were maintained frozen at −20◦C in
Trypticase Soy Broth (TSB) (Britania) containing 20% glycerol.
Bacterial Identification
Bacterial isolates were identified by conventional bacteriological
methods and then confirmed by 16 rRNA -sequencing and
additionally by matrix assisted laser desorption/ionization—time
of flight mass spectrometry (MALDI-TOF MS system—Bruker
Daltonik MALDI Biotyper). 16 rRNA -sequencing was carried
out by CERELA-CONICET sequencing service. DNA sequence
information was searched with Basic Local Alignment Search
Tool (BLAST) using the NCBI database. MALDI-TOF analysis
was performed by Microbiology Laboratory of the Hospital
Privado Universitario de Córdoba service. In brief, a score
of <1.700 was interpreted as no identification, 1.700–1.999
indicated an identification to genus level, 2.000–2.299 indicated
a reliable identification of the genus and a probable species
identification, and 2.300–3.000 represented a high probability of
species identification.
Minimal Inhibitory Concentration and
Minimal Bactericide Concentration Assay
The microdilution method was employed to determine the
Minimal Inhibitory Concentration (MIC) and MCB for EO
and limonene against bacterial isolates according to the
recommendations of the National Committee for Clinical
Laboratory Standards as described by Montironi et al. (10).
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Each concentration of EO or limonene was assayed four times
and the experiment was repeated on 3 different occasions.
Time Kill Assay
Decrease of bacteria was determined over several hours
according to El Kolli et al. (13). A concentration corresponding to
the MIC of the EO and limonene at a concentration that showed
the best inhibitory effect were used.
Bacterial Lysis
The bacteriolytic action was measured by absorbance at OD620
nm according to El Kolli et al. (13). The concentration
corresponding to the MIC, and limonene at a concentration that
showed the best inhibitory effect were assayed.
Random Amplified Polymorphic DNA
(RAPD) Analysis
RAPD-PCR assay was performed in order to detect DNA
alterations after addition of EO and limonene MIC. Results were
compared with RAPD-PCR assay without addition of EO and
limonene. Approximately 25 ng of chromosomal DNA was used
according to the optimized protocol in our lab (14). Primer P13-
5′-ACCGCCTGCT-3′ was used. A positive and a negative control
were used in each run. Each isolate was assayed twice. Amplified
products were determined by electrophoresis in 1.5% of agarose
gel (Promega) in 0.5 X TBE at 90V for 50min. Gels stained with
GelGreenTM were observed under UV light with MiniBisPRO
gel documentation (BioAmerica, USA) and recorded. A 100 bp
DNA marker (Promega) was used as a DNA molecular size
standard. Band profiles were compared for similarity by visual
inspection.
Biofilm Assays
The ability of the bacterial isolates to form biofilm in vitro on an
abiotic surface was determined using a sterile 96-well flat bottom
polystyrene plate as previously described (4). A Staphylococcus
epidermidis strain was used as positive control and TSB as
negative control. The effect of adding sugars as sucrose (5%) and
lactose (5%) and milk compounds as skim milk powder (5%)
(OxoidTM) and casein hydrolysate (3 mg/ml) was determined.
All the additives and casein hydrolysate were purchased at Sigma,
St. Louis, MO, USA.
Inhibitory Effect of EO and Limonene on
Biofilm Formation
The activity of EO and limonene was evaluated in the prevention
of biofilm formation. MIC levels of EO and limonene previously
determined were added to a bacterial suspension of 106 cfu/ml
and the 96-well flat bottom polystyrene plates were incubated at
37◦ C for 24 h. Four wells in each plate containing only EO or
limonene were used as negative controls. The wells were washed
and colored according to Moliva et al. (4). The effect of MIC on
biofilm formation was determined according to Aiemsaard et al.
(15). Percentages of inhibition for each sample were determined
by comparing the mean optical density of control wells (without
EO or limonene added) with the bacterial suspension (with the
addition of EO or limonene) using the following formula:
[1− (OD560sample/OD560control)]×100%
Each concentration of EO or limonene was assayed four times
and the experiment was repeated on 3 different occasions.
Effect of EO and Limonene on Mature
Biofilm
The stability of the biofilm against EO and limonene in mature
biofilms was determined according to the protocol described
above, except that EO and limonene were added to the wells 24 h
after biofilm formation. Absorbance at OD560 nm was read and
percentages of inhibition were calculated.
Statistical Analysis
Statistical analysis was performed using Graphpad Prism.
Analysis of variance (ANOVA) and the Tukey multiple
comparison test were used. The nominal p-value for statistical
significance was p ≤ 0.05.
RESULTS
Essential Oil Extraction
Chromatographic profile of EO showed the presence of pulegone
and menthone, identified as major components with percentages
of 74.96 and 20.38%, respectively. Other compounds included
were limonene (1.50%), α-pinene (0.48%) and β-pinene (0.50%).
The sum of the relative percentages of the compounds
identified in EO was 97.86%. The remaining percentage (2.14%)
corresponds to compounds that could not be identified.
Bacterial Identification
The bacterial isolates were identified by conventional
bacteriological methods and later confirmed by 16 rRNA
sequencing and MALDI-TOF analysis. The isolates were
identified as Escherichia coli (named EC3 and EC9), Bacillus
pumilus (named BP5, BP6 and BP7) and Enterococcus faecium
(named EF1).
Minimal Inhibitory Concentration and
Minimal Bactericide Concentration
The antibacterial activity of EO and one of its component
limonene was assayed against the bovine mastitis isolated. MIC
andMBC of EO and limonene were determined. Results obtained
showed that EO inhibited the growth of all isolates. On the other
hand, limonene had an inhibitory effect on BP5 and BP6 isolates.
MIC values for EO were 3.6 mg/ml for E. faecium; 0.9 mg/ml
for E. coli (EC3), 14.5 mg/ml for E. coli (EC9), 1.8 mg/ml for
B. pumilus (BP7), 3.63 mg/ml for B. pumilus (BP6) and 29.0
mg/ml for B. pumilus (BP7). MIC values for limonene were 6.6
mg/ml for B. pumilus (BP6) and 105 mg/ml for B. pumilus (BP5).
On the other hand, EO had bactericidal effect on EF1 isolate
at a high concentration (MBC= 29.0mg / ml) and limonene had
no bactericidal action on any isolate (Table 1).
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Time Kill Assay
The time of death was evaluated by bacterial decrease in all
the isolates treated with the MIC of EO and limonene or the
concentration of limonene that showed the best inhibitory effect
against bacteria.
Results showed that EF1 strain treated with the MIC of
EO, significantly reduced the population after 6 h of treatment
(p < 0.01). On the other hand, limonene showed no effect
(Figure 1).
The effect of EO and limonene was also evaluated in isolates
where these compounds did not show bactericidal action. No
difference was observed in bacterial count at the different times
assayed.
Bacterial Lysis
Bacterial lysis was determined in EF1 isolate, evaluating the
addition effect of the MIC of EO or the limonene concentration
that showed the best inhibitory effect against EF1 (52.5 mg/ml).
Results obtained showed that EO was able to produce 50% of
bacterial lysis (p < 0.05) after 30min (Figure 2). On the other
hand, limonene did not produce bacterial lysis.
Furthermore, EO and limonene were also tested for lysis
production on the remaining isolates and no bacterial lysis was
observed. In addition, the activity of the EO against the bacteria
TABLE 1 | Minimal inhibitory concentration (MIC) of EO and limonene.
Minimum inhibitory concentration (MIC)
EO (mg/ml) Limonene (mg/ml)
Enterococcus faecium (EF1) 3.63 –
Escherichia coli (EC3) 14.51 –
Escherichia coli (EC9) 0.90 –
Bacillus pumilus (BP5) 29.0 105
Bacillus pumilus (BP6) 3.63 6.6
Bacillus pumilus (BP7) 1.8 –
(–) = no MIC was observed.
tested was assayed over the time without achieving at the absence
of viable forms, except for EF1.
Random Amplified Polymorphic DNA
(RAPD) Analysis
Variations in RAPD profiles after addition of MIC of EO and
limonene at the concentration that showed the best inhibitory
effect was observed as variations in band intensity in the isolates
assayed. Figure 3 shows the RAPD-PCR profiles of the EC9 and
EF1 isolates after adding EO or limonene.
Biofilm Assays
Results showed that all the isolates were able to form biofilm in
vitro. Addition of lactose or sucrose to the culture media did not
affect biofilm production. B. pumilus (BP6) showed a decrease
in the biofilm production, although it seems to affect biofilm
production, it is not statistically significant respect to the control.
Figure 4 shows the effect of each carbohydrate addition.
Addition of skim milk showed a slight increase in biofilm
production in isolates EF1, BP5, BP7, and EC9, but no statistical
difference was found. Similar results were obtained after addition
of casein hydrolysate in strains BP5, BP7, and EC9 which showed
a minor increase in biofilm production (Figure 5).
Effect of EO and Limonene During Biofilm
Formation and on Mature Biofilm
The action of EO and limonene during biofilm formation and on
mature biofilm was studied using MICs previously determined.
In the isolates in which it was not possible to determine the MIC
of limonene, the concentration that showed the best inhibitory
effect against bacteria was used (52.5 mg/ml for EF1, 210 mg/ml
for EC3, 105 mg/ml for EC9 and 210 mg/ml for BP7).
Inhibition percentages among 36.51 and 89.60% were
observed after EO addition, between 22.06 and 89.83% of
inhibition was observed when limonene was added during
biofilm formation (Figure 6).
Inhibition percentages of EO from 35.06 to 66.35%, and
limonene from 33.36 to 61% were observed on mature biofilm
were observed on mature biofilm (Figure 7).
FIGURE 1 | Bacterial counts of EF1 isolate after MIC of EO and limonene at concentration that showed the best inhibitory effect against EF1. **p < 0.01 compared
with EF1 alone. Each value represents means ± SD.
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FIGURE 2 | Effect of EO and limonene on bacterial lysis. *p < 0.05 compared with EF1 alone. Each value represents means ± SD.
FIGURE 3 | RAPD-PCR profiles among isolates after addition of EO or
limonene. Lane 1: EC9 after addition of EO; lane 2: EC9 after addition
of limonene; lane 3: EF1 after addition of EO; lane 4: EF1 after addition of
limonene; lane 5: EF1 isolate without treatment; lane 6: EC9 isolate without
treatment; lane M: Molecular marker, 100 bp DNA ladder.
DISCUSSION
The drawbacks of antibiotic therapy and the difficulties in
eliminating infections associated with the biofilm have guided
the search for alternative therapeutic agents. Previously, we have
demonstrated the antibacterial activity of both EO and limonene
on pathogens isolated from bovine mastitis as Staphylococcus
aureus and coagulase negative staphylococci (11). In the present
work, the inhibitory effect of theM. verticillata EO and limonene
was determined on mastitis pathogens able to form biofilm in
vitro.
The chromatographic profile of EO was similar to a previously
one reported by Montironi et al. (10), with a predominantly
pulegone-menthone chemotype.
All bacterial isolates identified in the present work correspond
to environmental pathogens. Methods to control these bacteria
sometimes are inadequate (16). Enterococcus spp. are part of
the normal flora of urogenital and gastrointestinal systems of
mammals. They live in different niches as soil, natural waters and
plants. E. faecium and Enterococcus faecalis are cause of bovine
mastitis (17). Enterococcus group is important due to their ability
to transfer conjugative plasmids (18) increasing the virulence by
antibiotic resistance and leading to an important problem in the
therapeutic treatment.
E. coli is found in organic materials as dung and bedding. The
contact with organic matter and the milking process favor the
infection of the udder. The proportion of E. coli as a causative
agent in bovine clinical mastitis varies between countries. Bovine
mastitis caused by E. coli can range from mild to moderate
clinical signs and usually have a natural cure (19, 20). Although,
sometimes can produced a severe systemic disease.
However, E. coli strains may turn into chronic or
recurrent infections and antimicrobial therapy with the use
of fluoroquinolones and cephalosporins becomes necessary.
Nevertheless, both antibiotics should be used in animals destined
for food under specific indications and after a microbiological
diagnosis (21).
Bacillus spp. comprise a varied group of bacteria disseminated
in soil and water environment. They could infect the mammary
gland when cows have access to pasture or through dirty
infusions prior to intramammary treatment or dry cow therapy.
Reports have showed that different Bacillus species including
B. pumilus are able to cause infections (22). Nieminen et al.
(23) could identify Bacillus as the major organism in 23 mastitic
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FIGURE 4 | Effect of addition of sucrose (A) and lactose (B) on biofilm formation. Each value represents means ± SD.
FIGURE 5 | Effect of addition of skim milk (A) and lactose casein hydrolysate (B). Each value represents means ± SD.
FIGURE 6 | Inhibitory effects of EO and limonene during biofilm formation.
**p < 0.01 compared with limonene. Each value represents means ± SD.
milk samples where four of them were B. pumilus. Similarly,
Amer et al. (24) found Bacillus spp. in 22.1% of isolates. The
presence of Bacillus spp. may risk the quality guarantee of milk
products.
FIGURE 7 | Inhibitory effects of EO and limonene on mature biofilm *p < 0.05
compared with limonene. Each value represents means ± SD.
The results of MIC and MBC values showed that EO
has antibacterial activity against clinical isolate bovine mastitis
pathogens. MIC results showed that EO was able to inhibit
the growth of all isolates tested in lower concentrations than
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limonene, demonstrating that EO was the most effective.
Furthermore, in this study it was observed that concentrations
of EO required to inhibit most of the Gram-positive bacteria were
lower than those required to inhibit the growth of Gram-negative
bacteria, except for BP5 and EC9. On the other hand, limonene
only had inhibitory action on Gram-positive bacteria tested. The
results obtained were similar to those reported by other authors.
Klancnik et al. (25) determined MIC and MBC values of four
extracts of rosemary (Rosmarinus officinalis) soluble in oil and
water, against Gram positive (Bacillus spp. and Staphylococcus
spp.) and Gram negative bacteria (Campylobacter spp. and
Salmonella spp.) showing that Gram-positive bacteria were more
sensitive than Gram-negative bacteria.
Results of time of death assays are according to those observed
in the MBC test, in which the bactericidal action of EO was
observed on EF1 isolate. On the other hand, it was found that
limonene, which had not shown bactericidal action in EF1 isolate,
also failed significantly to decrease the bacterial population.
No difference was observed in bacterial count at different
times assayed after the addition of EO and limonene in isolates
where these compounds did not show bactericidal action.
Results of lysis production are in agreement with those of El
Kolli et al. (13) who reported that the absorbance relative values
decreased significantly to 35.3% for Bacillus cereus and 40% for
Proteus mirabilis when the essential oil of Daucus gracilis was
studied.
Variations in RAPD profiles were reported by Hamedo (26)
who studied the antimicrobial activity of the essential oils of
Rosmarinus officinalis. The authors found that differences in
RAPD profiles could be due to DNA damage after essential oils
addition, although the differences could also be attributed to the
oligonucleotide used (26). Changes in bands intensity were found
in this study, suggesting no DNA damage.
In the present study, all the isolates were able to form biofilm,
although the addition of carbohydrates did not affect biofilm
production. Similar results were obtained by Moliva et al. (4),
who reported that addition of lactose (0.5 and 5%) in the culture
medium did not promote biofilm formation in S. uberis isolates.
However, results are in contrast to those reported by Abureema
(3) who informed that that addition of lactose decreased biofilm
formation and the addition of fructose, glucose, or sucrose
increased biofilm formation by S. uberis.
Results obtained after addition of skim milk or α-casein
are in accordance with those reported by Tasi et al. (27),
who demonstrated that S. uberis isolates grown in BME-UV1
complete medium with the addition of casein did not increase
biofilm production. Likewise, Atulya et al. (28) showed milk
components did not affect biofilm formation in E. coli and
S. aureus isolates. According to the literature, several factors and
additives can influence the formation of biofilm in the different
genera of bacteria.
The effects of EO in inhibiting biofilm formation was
determined. Addition of both EO and limonene significantly
reduced the production of biofilm in all isolates tested as mature
biofilm. Our results agree with other reports. Montironi et al. (10)
informed that EO and limonene were able to decrease biofilm
production in Streptococcus uberis isolates. Similarly, Aiemsaard
et al. (15) showed that limonene was able to inhibit biofilm
formation as mature biofilm in Staphylococcus aureus isolates.
Findings of the present study showed that higher inhibition
percentages were obtained during biofilm formation, suggesting
that both compounds were more effective at this stage.
CONCLUSION
The results obtained in the present work contribute to the study
of Minthostachys verticillata EO and limonene. Findings of the
present report showed that EO affected the formation of biofilm
and revealed the antibacterial capacity of EO and limonene
suggesting its possible use as an alternative or complementary
therapy in the control of bovine mastitis.
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